Across TCGA pan-cancer cohorts, RNU2-40P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNU2-40P data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RNU2-40P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU2-40P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.
KIRP, TGCT, and READ are the cancer types where RNU2-40P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.